Research and Markets (http://www.researchandmarkets.com/research/ljpsr8/global_psoriasis) has announced the addition of the "Global Psoriasis Therapeutics Market 2015-2019" report to their offering.

The analysts forecast the Global Psoriasis Therapeutics market to grow at a CAGR of 9.95% over the period 2014-2019.

The dominance of the market by biologics is one major trend in this market. It is expected to be a preferred choice of treatment among patients, their families, and the medical community. This, in turn, is expected to raise the number of treatment-seeking patients, which is expected to result in an increase in the overall consumption of medicines.

According to the report, growing unmet needs in terms of the availability of appropriate drugs is one of the major factors propelling the growth of the market. Current treatment options cannot cure the disease completely, and the drugs have a low safety profile. Therefore, drugs with a high safety profile that can cause remission of the disease in patients will boost the growth of the market.

Further, the report states that the unknown etiology of psoriasis is one of the major challenges hindering the growth of the market. This makes it difficult for drug manufacturers to develop a targeted therapy for its treatment. Though psoriasis is an autoimmune disorder, the cause of the disease is still unknown. However, the pathogenesis of psoriasis is thought to be associated with the formation of abnormal keratin, epidermal proliferation, immune system activation, and genetic factors.

To calculate the market size, the report considers revenue generated from the sales of various drugs including systemic and topical drugs used in the treatment of:

  • Psoriasis
  • Psoriatic Arthritis

The Global Psoriasis Therapeutics market is segmented based on the mechanism of action of the drugs used to treat psoriasis and psoriatic arthritis as illustrated below:

  • TNF Inhibitors
  • PDE4 Inhibitors
  • Interleukin Blockers
  • Others

The Global Psoriasis Therapeutics market is also segmented based on the type of molecule used for the treatment of psoriasis, as illustrated below:

  • Biologics
  • Small Molecules

On the basis of route of administration adopted for the treatment of psoriasis, the Global Psoriasis Therapeutics market is segmented as follows:

  • Oral
  • Parenteral
  • Topical

Key Vendors

  • Abbvie
  • Amgen
  • Janssen Pharmaceuticals
  • Pfizer

For more information visit http://www.researchandmarkets.com/research/ljpsr8/global_psoriasis